clarithromycin

clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.

Cross Reference

Introduction

To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with clarithromycin?

clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with clarithromycin

MeSH term MeSH ID Detail
Periodontitis D010518 22 associated lipids
Fibrosis D005355 23 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Stomach Neoplasms D013274 24 associated lipids
Genetic Predisposition to Disease D020022 24 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Nasal Polyps D009298 26 associated lipids
Gastrointestinal Hemorrhage D006471 27 associated lipids
Angina Pectoris D000787 27 associated lipids
Gastritis D005756 27 associated lipids
Endometriosis D004715 29 associated lipids
Drug Eruptions D003875 30 associated lipids
Proteinuria D011507 30 associated lipids
Diarrhea D003967 32 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Fever D005334 35 associated lipids
Heart Failure D006333 36 associated lipids
Lung Diseases D008171 37 associated lipids
Arthritis D001168 41 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Psoriasis D011565 47 associated lipids
Parkinson Disease D010300 53 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Pain D010146 64 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Colitis D003092 69 associated lipids
Hyperlipidemias D006949 73 associated lipids
Stomach Ulcer D013276 75 associated lipids
Arteriosclerosis D001161 86 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Insulin Resistance D007333 99 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Hemolysis D006461 131 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 242

PubChem Associated disorders and diseases

What pathways are associated with clarithromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with clarithromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with clarithromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with clarithromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with clarithromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with clarithromycin?

Mouse Model

Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).

Knock-out

Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).

Experimental Pneumococcal Meningitis

Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with clarithromycin

Download all related citations
Per page 10 20 50 100 | Total 7636
Authors Title Published Journal PubMed Link
Liu WH et al. In vitro anti-Helicobacter pylori activity of diallyl sulphides and protocatechuic acid. 2008 Phytother Res pmid:17705145
Lawal TO et al. Combination studies of Eucalyptus torelliana F. Muell. leaf extracts and clarithromycin on Helicobacter pylori. 2012 Phytother Res pmid:22318891
MAC management. 1996 PI Perspect pmid:11363967
Cheng B Preventing opportunistic infections. 1995 PI Perspect pmid:11362422
Kwak HM et al. The efficacy of cefazolin plus macrolide (erythromycin or clarithromycin) versus cefazolin alone in neonatal morbidity and placental inflammation for women with preterm premature rupture of membranes. 2013 Placenta pmid:23465535
Dantas da Silva LL et al. Antibacterial activity of a stearic acid derivative from Stemodia foliosa. 2002 Planta Med. pmid:12494347
Lee D et al. Localized Mycobacterium avium-intracellulare mastitis in an immunocompetent woman with silicone breast implants. 1995 Plast. Reconstr. Surg. pmid:7809228
Hess CL et al. Mycobacterium marinum infections of the upper extremity. 2005 Plast. Reconstr. Surg. pmid:15731663
Matsukawa Y et al. Long term changes in platelet counts after H. pylori eradication in non-ITP patients. 2010 Platelets pmid:20849211
Matsukawa Y et al. Helicobacter pylori eradication reduces platelet count in patients without idiopathic thrombocytopenic purpura. 2007 Platelets pmid:17365854
Fouts DE et al. Major structural differences and novel potential virulence mechanisms from the genomes of multiple campylobacter species. 2005 PLoS Biol. pmid:15660156
Balcan D et al. Modeling the critical care demand and antibiotics resources needed during the Fall 2009 wave of influenza A(H1N1) pandemic. 2009 PLoS Curr pmid:20029670
Letek M et al. The genome of a pathogenic rhodococcus: cooptive virulence underpinned by key gene acquisitions. 2010 PLoS Genet. pmid:20941392
Connolly LE et al. Why is long-term therapy required to cure tuberculosis? 2007 PLoS Med. pmid:17388672
Corrales-Medina VF et al. Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. 2011 PLoS Med. pmid:21738449
Skalet AH et al. Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial. 2010 PLoS Med. pmid:21179434
Chauffour A et al. Sterilizing Activity of Fully Oral Intermittent Regimens against Mycobacterium Ulcerans Infection in Mice. 2016 PLoS Negl Trop Dis pmid:27755552
Converse PJ et al. Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease. 2015 PLoS Negl Trop Dis pmid:26042792
Friedman ND et al. Mycobacterium ulcerans disease: experience with primary oral medical therapy in an Australian cohort. 2013 PLoS Negl Trop Dis pmid:23875050
Cowan R et al. Mycobacterium ulcerans treatment--can antibiotic duration be reduced in selected patients? 2015 PLoS Negl Trop Dis pmid:25658304
Gopinath K and Singh S Non-tuberculous mycobacteria in TB-endemic countries: are we neglecting the danger? 2010 PLoS Negl Trop Dis pmid:20436962
Vinh H et al. A multi-center randomized trial to assess the efficacy of gatifloxacin versus ciprofloxacin for the treatment of shigellosis in Vietnamese children. 2011 PLoS Negl Trop Dis pmid:21829747
Almeida D et al. Activities of rifampin, Rifapentine and clarithromycin alone and in combination against mycobacterium ulcerans disease in mice. 2011 PLoS Negl Trop Dis pmid:21245920
Hobbie SN et al. Genetic reconstruction of protozoan rRNA decoding sites provides a rationale for paromomycin activity against Leishmania and Trypanosoma. 2011 PLoS Negl Trop Dis pmid:21629725
Trunck LA et al. Molecular basis of rare aminoglycoside susceptibility and pathogenesis of Burkholderia pseudomallei clinical isolates from Thailand. 2009 PLoS Negl Trop Dis pmid:19771149
Gordon CL et al. All-oral antibiotic treatment for buruli ulcer: a report of four patients. 2010 PLoS Negl Trop Dis pmid:21152060
O'Brien DP et al. Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort study. 2012 PLoS Negl Trop Dis pmid:22272368
Cusini A et al. Different patterns of inappropriate antimicrobial use in surgical and medical units at a tertiary care hospital in Switzerland: a prevalence survey. 2010 PLoS ONE pmid:21103362
Miftahussurur M et al. Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations. 2016 PLoS ONE pmid:27906990
DeLisle S et al. Combining free text and structured electronic medical record entries to detect acute respiratory infections. 2010 PLoS ONE pmid:20976281
Davies EC et al. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. 2009 PLoS ONE pmid:19209224
Lee SJ et al. Clarithromycin Attenuates Radiation-Induced Lung Injury in Mice. 2015 PLoS ONE pmid:26114656
Eickel V et al. Emergence of respiratory Streptococcus agalactiae isolates in cystic fibrosis patients. 2009 PLoS ONE pmid:19247473
Yonezawa H et al. Impact of Helicobacter pylori biofilm formation on clarithromycin susceptibility and generation of resistance mutations. 2013 PLoS ONE pmid:24039906
McNaghten AD et al. Improving the representativeness of behavioral and clinical surveillance for persons with HIV in the United States: the rationale for developing a population-based approach. 2007 PLoS ONE pmid:17579722
Greenstein RJ et al. On the action of 5-amino-salicylic acid and sulfapyridine on M. avium including subspecies paratuberculosis. 2007 PLoS ONE pmid:17565369
Huh CW et al. Early Attempts to Eradicate Helicobacter pylori after Endoscopic Resection of Gastric Neoplasm Significantly Improve Eradication Success Rates. 2016 PLoS ONE pmid:27588679
Rose SJ et al. Mycobacterium avium Possesses Extracellular DNA that Contributes to Biofilm Formation, Structural Integrity, and Tolerance to Antibiotics. 2015 PLoS ONE pmid:26010725
Greenstein RJ et al. Vitamins A & D inhibit the growth of mycobacteria in radiometric culture. 2012 PLoS ONE pmid:22235314
Christianson S et al. Time-to-Detection of Inducible Macrolide Resistance in Mycobacterium abscessus Subspecies and Its Association with the Erm(41) Sequevar. 2016 PLoS ONE pmid:27490181
Liou JM et al. The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors-A Nationwide Study. 2015 PLoS ONE pmid:25942450
Greenstein RJ et al. On the action of cyclosporine A, rapamycin and tacrolimus on M. avium including subspecies paratuberculosis. 2008 PLoS ONE pmid:18575598
Ren YR et al. Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytes. 2008 PLoS ONE pmid:19104661
Ishiguro N et al. Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients. 2017 PLoS ONE pmid:28288170
Greenstein RJ et al. The thioamides methimazole and thiourea inhibit growth of M. avium Subspecies paratuberculosis in culture. 2010 PLoS ONE pmid:20559419
Palacios-Chaves L et al. Brucella abortus ornithine lipids are dispensable outer membrane components devoid of a marked pathogen-associated molecular pattern. 2011 PLoS ONE pmid:21249206
Hirasawa K et al. Macrolide Antibiotics Exhibit Cytotoxic Effect under Amino Acid-Depleted Culture Condition by Blocking Autophagy Flux in Head and Neck Squamous Cell Carcinoma Cell Lines. 2016 PLoS ONE pmid:27977675
Shinahara W et al. Immunomodulator clarithromycin enhances mucosal and systemic immune responses and reduces re-infection rate in pediatric patients with influenza treated with antiviral neuraminidase inhibitors: a retrospective analysis. 2013 PLoS ONE pmid:23875018
Greenstein RJ et al. On the action of methotrexate and 6-mercaptopurine on M. avium subspecies paratuberculosis. 2007 PLoS ONE pmid:17252054
Peedikayil MC et al. Levofloxacin-based first-line therapy versus standard first-line therapy for Helicobacter pylori eradication: meta-analysis of randomized controlled trials. 2014 PLoS ONE pmid:24465624
Jakobsson HE et al. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. 2010 PLoS ONE pmid:20352091
Chu HS et al. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense. 2015 PLoS ONE pmid:25581038
Berende A et al. Cost-effectiveness of longer-term versus shorter-term provision of antibiotics in patients with persistent symptoms attributed to Lyme disease. 2018 PLoS ONE pmid:29608590
Dalkmann P et al. Accumulation of pharmaceuticals, Enterococcus, and resistance genes in soils irrigated with wastewater for zero to 100 years in central Mexico. 2012 PLoS ONE pmid:23049795
Andersen JT et al. Clarithromycin in early pregnancy and the risk of miscarriage and malformation: a register based nationwide cohort study. 2013 PLoS ONE pmid:23301061
Salmi C et al. Squalamine: an appropriate strategy against the emergence of multidrug resistant gram-negative bacteria? 2008 PLoS ONE pmid:18648511
Juste RA et al. On the prevalence of M. avium subspecies paratuberculosis DNA in the blood of healthy individuals and patients with inflammatory bowel disease. 2008 PLoS ONE pmid:18596984
Wu TS et al. Fish tank granuloma caused by Mycobacterium marinum. 2012 PLoS ONE pmid:22911774
Raymond J et al. Using macro-arrays to study routes of infection of Helicobacter pylori in three families. 2008 PLoS ONE pmid:18493595
Hashim H et al. Eradication of Helicobacter pylori infection improves levodopa action, clinical symptoms and quality of life in patients with Parkinson's disease. 2014 PLoS ONE pmid:25411976
Robertson HT and Allison DB Drugs associated with more suicidal ideations are also associated with more suicide attempts. 2009 PLoS ONE pmid:19798416
Ramírez-Lázaro MJ et al. Real-time PCR improves Helicobacter pylori detection in patients with peptic ulcer bleeding. 2011 PLoS ONE pmid:21625499
Kim BJ et al. Discovery of a novel hsp65 genotype within Mycobacterium massiliense associated with the rough colony morphology. 2012 PLoS ONE pmid:22693637
Tebruegge M et al. Nontuberculous Mycobacterial Disease in Children - Epidemiology, Diagnosis & Management at a Tertiary Center. 2016 PLoS ONE pmid:26812154
Blumenthal A et al. M. tuberculosis induces potent activation of IDO-1, but this is not essential for the immunological control of infection. 2012 PLoS ONE pmid:22649518
Matsumoto Y et al. Evaluation of multidrug efflux pump inhibitors by a new method using microfluidic channels. 2011 PLoS ONE pmid:21533264
Ripoll F et al. Non mycobacterial virulence genes in the genome of the emerging pathogen Mycobacterium abscessus. 2009 PLoS ONE pmid:19543527
Boisson-Dupuis S et al. IL-12Rβ1 deficiency in two of fifty children with severe tuberculosis from Iran, Morocco, and Turkey. 2011 PLoS ONE pmid:21533230
van der Linden M et al. Molecular characterization of pneumococcal isolates from pets and laboratory animals. 2009 PLoS ONE pmid:20011527
Lu ZM et al. Nucleosomes correlate with in vivo progression pattern of de novo methylation of p16 CpG islands in human gastric carcinogenesis. 2012 PLoS ONE pmid:22558275
Everett DB et al. Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi. 2011 PLoS ONE pmid:21423577
Shin SH et al. Helicobacter pylori Eradication Prevents Metachronous Gastric Neoplasms after Endoscopic Resection of Gastric Dysplasia. 2015 PLoS ONE pmid:26580072
Wu Y et al. Overexpression of YKL-40 predicts plaque instability in carotid atherosclerosis with CagA-positive Helicobacter pylori infection. 2013 PLoS ONE pmid:23573226
Desai S et al. The Epidemiology of Invasive Haemophilus influenzae Non-Serotype B Disease in Ontario, Canada from 2004 to 2013. 2015 PLoS ONE pmid:26569613
Hardy RD et al. Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to Mycoplasma pneumoniae CARDS toxin. 2009 PLoS ONE pmid:19859545
Ribeiro CM et al. Azithromycin treatment alters gene expression in inflammatory, lipid metabolism, and cell cycle pathways in well-differentiated human airway epithelia. 2009 PLoS ONE pmid:19503797
Teh X et al. Functional and molecular surveillance of Helicobacter pylori antibiotic resistance in Kuala Lumpur. 2014 PLoS ONE pmid:25003707
Radzikowska E et al. Cryptogenic organizing pneumonia-Results of treatment with clarithromycin versus corticosteroids-Observational study. 2017 PLoS ONE pmid:28945804
Vadwai V et al. Clonal population of Mycobacterium tuberculosis strains reside within multiple lung cavities. 2011 PLoS ONE pmid:21935462
Hahn DL et al. Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity. 2012 PLoS ONE pmid:22545149
Tan B et al. Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial. 2017 PLoS ONE pmid:28407007
Rubio M et al. Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Complex. 2015 PLoS ONE pmid:26448181
Shea BJ et al. External validation of a measurement tool to assess systematic reviews (AMSTAR). 2007 PLoS ONE pmid:18159233
Martins TG et al. Local and regional re-establishment of cellular immunity during curative antibiotherapy of murine Mycobacterium ulcerans infection. 2012 PLoS ONE pmid:22393444
Li Y et al. A data-driven predictive approach for drug delivery using machine learning techniques. 2012 PLoS ONE pmid:22384063
Lai JF et al. Critical role of macrophages and their activation via MyD88-NFκB signaling in lung innate immunity to Mycoplasma pneumoniae. 2010 PLoS ONE pmid:21203444
Correia M et al. Docosahexaenoic acid inhibits Helicobacter pylori growth in vitro and mice gastric mucosa colonization. 2012 PLoS ONE pmid:22529974
Makobongo MO et al. In vitro characterization of the anti-bacterial activity of SQ109 against Helicobacter pylori. 2013 PLoS ONE pmid:23935905
Marsollier L et al. Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis. 2007 PLoS Pathog. pmid:17480118
Dorer MS et al. DNA damage triggers genetic exchange in Helicobacter pylori. 2010 PLoS Pathog. pmid:20686662
Namkoong H et al. Clarithromycin expands CD11b+Gr-1+ cells via the STAT3/Bv8 axis to ameliorate lethal endotoxic shock and post-influenza bacterial pneumonia. 2018 PLoS Pathog. pmid:29621339
Ankomah P and Levin BR Two-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinum. 2012 PLoS Pathog. pmid:22253599
Conde-Álvarez R et al. The lipopolysaccharide core of Brucella abortus acts as a shield against innate immunity recognition. 2012 PLoS Pathog. pmid:22589715
Schreiber J et al. [Non-tubercular mycobacterial infection of the lungs due to Mycobacterium smegmatis]. 2001 Pneumologie pmid:11449609
[Bronchial asthma--clarithromycin depresses neutrophil inflammation]. 2009 Pneumologie pmid:19165701
Handrick W et al. [Pulmonary infection due to Mycobacterium malmoense]. 2005 Pneumologie pmid:15944898
Radzikowska E et al. [Organizing pneumonia--own experiences with clarithromycin treatment]. 2004 Pneumonol Alergol Pol pmid:16329349
Radzikowska E et al. [Organizing pneumonia--clarithromycin treatment]. 2008 Pneumonol Alergol Pol pmid:19003763
Michałowska-Mitczuk D [Patients with chronic sputum positive tuberculosis-a therapeutic problem]. 1995 Pneumonol Alergol Pol pmid:7633360
Radzikowska E et al. [Organizing pneumonia--analysis of 18 own cases]. 2004 Pneumonol Alergol Pol pmid:15757271